Santa Cruz Biotechnology delivers a wide array of FAM123A Antibodies for research focused on understanding FAM123A protein functions. FAM123A Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). FAM123A, also known as FAM123A, plays a critical role in cellular processes such as cell adhesion and migration, which are essential for tissue development and repair. The involvement of FAM123A in signaling pathways makes it particularly relevant for cancer research and developmental biology studies. Research focusing on FAM123A functions can reveal important insights into disease mechanisms and identify potential therapeutic targets. Scientists working with FAM123A can explore its expression patterns across different tissues and cellular conditions. Investigating FAM123A interactions with other proteins helps uncover new regulatory mechanisms in cellular pathways. Understanding FAM123A's role in development and disease progression opens new avenues for therapeutic interventions. Santa Cruz Biotechnology monoclonal antibodies for FAM123A support researchers worldwide in advancing scientific understanding of cellular processes and disease mechanisms.